Ilumya Prices, Coupons, Copay Cards & Patient Assistance
Ilumya (tildrakizumab) is a member of the interleukin inhibitors drug class and is commonly used for Plaque Psoriasis, and Psoriasis.
Ilumya prices
Subcutaneous Solution
100 mg/mL Ilumya subcutaneous solution from $17,552.64 for 1 milliliter(s)
| Quantity | Per unit | Price |
|---|---|---|
| 1 milliliter | $17,552.64 | $17,552.64 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Ilumya Coupons, Copay Cards and Rebates
Ilumya offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Ilumya Copay Program
Eligible commercially insured patients may pay $0 per dose; maximum savings of $6,000 per calendar year.
- Applies to:
- Ilumya
- Number of uses:
- Per prescription per calendar year
Form more information phone: 855-445-8692 or Visit website
Ilumya Early Access Program
Eligible commercially insured patients whose coverage has been delayed or denied may be able to receive medication free for up to 2 years or until coverage is approved.
- Applies to:
- Ilumya
- Number of uses:
- Temporary Assistance
Form more information phone: 855-445-8692 or Visit website
Patient Assistance & Copay Programs for Ilumya
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Ilumya (tildrakizumab-asmn) Injection; Subcutaneous
More information please phone: 866-316-7263 Visit website
Provider: Ilumya Support Patient Assistance Program
Eligibility requirements:- Must be uninsured or underinsured
- At or below 400% of FPL
- Medically appropriate condition/diagnosis
- Must reside in the US, Guam, Puerto Rico or US Virgin Islands
- Co-payment assistance, reimbursement support, patient support, and patient assistance programs are available for eligible patients.
- Ilumya (tildrakizumab-asmn) Injection; Subcutaneous
More information please phone: 855-445-8692 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Ilumya (tildrakizumab)
- Check interactions
- Compare alternatives
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español